Related Experiment Video

Updated: Feb 26, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.4K

[Congenital heart disease mortality in Spain during a 10 year period (2003-2012)]

Javier Pérez-Lescure Picarzo1, Margarita Mosquera González2, Pello Latasa Zamalloa3

  • 1Cardiología Infantil, Área de Pediatría y Neonatología, Hospital Universitario Fundación Alcorcón, Alcorcón (Madrid), España.

Anales De Pediatria
|July 17, 2017
PubMed

Insights

Congenital heart disease remains a significant cause of infant mortality in Spain, with rates remaining constant over a decade. Certain severe congenital heart conditions, like hypoplastic left heart syndrome, show particularly high mortality rates.

Area of Science:

  • Pediatrics
  • Cardiology
  • Public Health

Background:

  • Congenital heart disease (CHD) is a leading cause of infant mortality in developed nations.
  • No prior national-level studies in Spain have comprehensively analyzed CHD-related infant mortality.
  • Understanding national mortality trends is crucial for public health interventions.

Purpose of the Study:

  • To analyze infant mortality rates associated with congenital heart disease in Spain.
  • To determine the lethality of specific types of congenital heart disease.
  • To examine trends in CHD mortality over a ten-year period (2003-2012).

Main Methods:

  • Retrospective observational study utilizing the minimum basic data set.
  • Inclusion of infants under one year old diagnosed with congenital heart disease.
  • Estimation of mortality rates and relative risk using Poisson regression.

Main Results:

  • 2,970 infant deaths (4.58%) occurred in 64,831 patients with CHD.
  • The infant mortality rate for CHD was 6.23 per 10,000 live births, remaining constant.
  • Hypoplastic left heart syndrome (41.4%), interruption of aortic arch (20%), and total anomalous pulmonary drainage (16.8%) had the highest mortality rates.

Conclusions:

  • Congenital heart disease remains a major, unvarying cause of infant mortality in Spain.
  • The proportion of infant deaths due to CHD in Spain is comparable to other developed countries.
  • Despite medical advancements, specific congenital heart conditions continue to present high mortality risks.
Abstract

Keywords:
Cardiopatías congénitasCongenital heart defectEpidemiologyEpidemiologíaInfant mortality rateMortalidad infantil

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.3K
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

7.4K

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
810
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
716
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
365
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
474